BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22638934)

  • 1. Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
    Guckenberger M; Saur G; Wehner D; Sweeney RA; Thalheimer A; Germer CT; Flentje M
    Strahlenther Onkol; 2012 Jul; 188(7):551-7. PubMed ID: 22638934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
    Guckenberger M; Saur G; Wehner D; Thalheimer A; Kim M; Germer CT; Flentje M
    Radiother Oncol; 2013 Aug; 108(2):326-30. PubMed ID: 24021342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04).
    Ansari N; Solomon MJ; Fisher RJ; Mackay J; Burmeister B; Ackland S; Heriot A; Joseph D; McLachlan SA; McClure B; Ngan SY
    Ann Surg; 2017 May; 265(5):882-888. PubMed ID: 27631775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients.
    Sterzing F; Hoehle F; Ulrich A; Jensen A; Debus J; Muenter M
    J Radiat Res; 2015 Jan; 56(1):169-76. PubMed ID: 25341424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-course preoperative radiotherapy combined with chemotherapy in resectable locally advanced rectal cancer: local control and quality of life.
    Ciammella P; Ruggieri MP; Galeandro M; D'Abbiero N; Giunta A; Iotti C
    Radiol Med; 2013 Dec; 118(8):1397-411. PubMed ID: 23801387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
    Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer.
    Crane CH; Skibber JM; Birnbaum EH; Feig BW; Singh AK; Delclos ME; Lin EH; Fleshman JW; Thames HD; Kodner IJ; Lockett MA; Picus J; Phan T; Chandra A; Janjan NA; Read TE; Myerson RJ
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):84-9. PubMed ID: 12909219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
    Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
    Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.
    Mowery YM; Salama JK; Zafar SY; Moore HG; Willett CG; Czito BG; Hopkins MB; Palta M
    Cancer; 2017 Apr; 123(8):1434-1441. PubMed ID: 27984651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer.
    Wang J; Long Y; Liu K; Pei Q; Zhu H
    BMC Gastroenterol; 2021 Jul; 21(1):277. PubMed ID: 34233606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer.
    McCarthy K; Pearson K; Fulton R; Hewitt J
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008368. PubMed ID: 23235660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancer.
    Doi H; Beppu N; Odawara S; Tanooka M; Takada Y; Niwa Y; Fujiwara M; Kimura F; Yanagi H; Yamanaka N; Kamikonya N; Hirota S
    J Radiat Res; 2013 Nov; 54(6):1118-24. PubMed ID: 23658415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society.
    Siegel R; Burock S; Wernecke KD; Kretzschmar A; Dietel M; Loy V; Koswig S; Budach V; Schlag PM
    BMC Cancer; 2009 Feb; 9():50. PubMed ID: 19200365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
    Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
    Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
    World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative long course chemoirradiation in a developing country for rectal carcinoma: Kuala Lumpur hospital experience.
    Lee WC; Yusof MM; Lau FN; Phua VC
    Asian Pac J Cancer Prev; 2013; 14(6):3941-4. PubMed ID: 23886211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of postoperative treatment for rectal cancer UICC stage II and III in day-to-day clinical practice. Results from a retrospective quality control analysis in six institutions in North Bavaria (Germany).
    Wulf J; Krämer K; van Aaken C; Dietzel F; Lucas D; Pfändner K; Schimpke T; Schulze W; Thiel HJ; Ziegler K; Flentje M
    Strahlenther Onkol; 2004 Jan; 180(1):5-14. PubMed ID: 14704839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The postoperative adjuvant radiation therapy and radiochemotherapy for UICC stage II and III rectal cancer. A retrospective analysis.
    Bagatzounis A; Willner J; Oppitz U; Flentje M
    Strahlenther Onkol; 2000 Mar; 176(3):112-7. PubMed ID: 10742831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative radiotherapy of locally advanced rectal cancer: clinical outcome of short-course and long-course treatment with or without concomitant chemotherapy.
    Krajcovicova I; Bolješíková E; Sandorova M; Zavodska A; Zemanová M; Chorváth M; Ondruš D
    Klin Onkol; 2012; 25(5):364-9. PubMed ID: 23102198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.